

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 6.61924062 |
| 2 | cellular ketone body metabolic process (GO:0046950) | 6.36756533 |
| 3 | ketone body metabolic process (GO:1902224) | 5.57932067 |
| 4 | regulation of memory T cell differentiation (GO:0043380) | 5.51921489 |
| 5 | drug catabolic process (GO:0042737) | 5.24695975 |
| 6 | exogenous drug catabolic process (GO:0042738) | 4.81647713 |
| 7 | regulation of fibrinolysis (GO:0051917) | 4.58659234 |
| 8 | phenylpropanoid metabolic process (GO:0009698) | 4.50368091 |
| 9 | serine family amino acid catabolic process (GO:0009071) | 4.46258885 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 4.33307151 |
| 11 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.26361877 |
| 12 | regulation of protein activation cascade (GO:2000257) | 4.25295859 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 4.22106764 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.10366859 |
| 15 | regulation of complement activation (GO:0030449) | 3.97038246 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 3.97017701 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.97017701 |
| 18 | cellular glucuronidation (GO:0052695) | 3.90443566 |
| 19 | centriole replication (GO:0007099) | 3.90194679 |
| 20 | negative regulation of protein activation cascade (GO:2000258) | 3.85698199 |
| 21 | drug metabolic process (GO:0017144) | 3.75851274 |
| 22 | glycine metabolic process (GO:0006544) | 3.75492643 |
| 23 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.75438401 |
| 24 | uronic acid metabolic process (GO:0006063) | 3.72081378 |
| 25 | glucuronate metabolic process (GO:0019585) | 3.72081378 |
| 26 | negative regulation of complement activation (GO:0045916) | 3.70932058 |
| 27 | macromolecular complex remodeling (GO:0034367) | 3.66086968 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66086968 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 3.66086968 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 3.62784624 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.54364301 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.54364301 |
| 33 | complement activation, alternative pathway (GO:0006957) | 3.51027254 |
| 34 | arginine metabolic process (GO:0006525) | 3.47442542 |
| 35 | alkaloid metabolic process (GO:0009820) | 3.47022830 |
| 36 | oxidative demethylation (GO:0070989) | 3.44216167 |
| 37 | phospholipid efflux (GO:0033700) | 3.43051574 |
| 38 | regulation of guanylate cyclase activity (GO:0031282) | 3.41021421 |
| 39 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.39719145 |
| 40 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.39675984 |
| 41 | urea metabolic process (GO:0019627) | 3.39641953 |
| 42 | cholesterol efflux (GO:0033344) | 3.37311371 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 3.27789522 |
| 44 | regulation of hexokinase activity (GO:1903299) | 3.26884180 |
| 45 | regulation of glucokinase activity (GO:0033131) | 3.26884180 |
| 46 | peptidyl-glutamic acid modification (GO:0018200) | 3.26438065 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 3.25557337 |
| 48 | microtubule polymerization or depolymerization (GO:0031109) | 3.25150567 |
| 49 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.24728892 |
| 50 | amino acid salvage (GO:0043102) | 3.23782695 |
| 51 | L-methionine salvage (GO:0071267) | 3.23782695 |
| 52 | L-methionine biosynthetic process (GO:0071265) | 3.23782695 |
| 53 | polyketide metabolic process (GO:0030638) | 3.21657528 |
| 54 | doxorubicin metabolic process (GO:0044598) | 3.21657528 |
| 55 | daunorubicin metabolic process (GO:0044597) | 3.21657528 |
| 56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.20550129 |
| 57 | protein carboxylation (GO:0018214) | 3.20550129 |
| 58 | auditory receptor cell stereocilium organization (GO:0060088) | 3.20063476 |
| 59 | protein polyglutamylation (GO:0018095) | 3.19720813 |
| 60 | flavonoid metabolic process (GO:0009812) | 3.18482136 |
| 61 | reverse cholesterol transport (GO:0043691) | 3.16804371 |
| 62 | fructose metabolic process (GO:0006000) | 3.16375267 |
| 63 | negative regulation of sterol transport (GO:0032372) | 3.16297073 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.16297073 |
| 65 | aromatic amino acid family catabolic process (GO:0009074) | 3.16111130 |
| 66 | organelle disassembly (GO:1903008) | 3.15331156 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 3.15209512 |
| 68 | bile acid and bile salt transport (GO:0015721) | 3.15115769 |
| 69 | protein targeting to Golgi (GO:0000042) | 3.14855856 |
| 70 | aldehyde catabolic process (GO:0046185) | 3.12911827 |
| 71 | S-adenosylmethionine metabolic process (GO:0046500) | 3.10783300 |
| 72 | urea cycle (GO:0000050) | 3.10497765 |
| 73 | heme transport (GO:0015886) | 3.09864110 |
| 74 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.08510621 |
| 75 | regulation of activation of Janus kinase activity (GO:0010533) | 3.08260527 |
| 76 | plasma lipoprotein particle organization (GO:0071827) | 3.08024198 |
| 77 | triglyceride homeostasis (GO:0070328) | 3.07702720 |
| 78 | acylglycerol homeostasis (GO:0055090) | 3.07702720 |
| 79 | regulation of meiosis I (GO:0060631) | 3.06943523 |
| 80 | iron-sulfur cluster assembly (GO:0016226) | 3.06507214 |
| 81 | metallo-sulfur cluster assembly (GO:0031163) | 3.06507214 |
| 82 | fibrinolysis (GO:0042730) | 3.06398709 |
| 83 | axoneme assembly (GO:0035082) | 3.05507383 |
| 84 | drug transmembrane transport (GO:0006855) | 3.05431495 |
| 85 | cytolysis (GO:0019835) | 3.04359103 |
| 86 | microtubule depolymerization (GO:0007019) | 3.03798967 |
| 87 | establishment of protein localization to Golgi (GO:0072600) | 3.02945043 |
| 88 | regulation of plasminogen activation (GO:0010755) | 3.02916850 |
| 89 | negative regulation of humoral immune response (GO:0002921) | 2.99829220 |
| 90 | ribonucleoprotein complex disassembly (GO:0032988) | 2.97006014 |
| 91 | mannosylation (GO:0097502) | 2.96419752 |
| 92 | arginine catabolic process (GO:0006527) | 2.96168507 |
| 93 | peroxisome fission (GO:0016559) | 2.94052923 |
| 94 | sulfur amino acid catabolic process (GO:0000098) | 2.90027329 |
| 95 | negative regulation of lipase activity (GO:0060192) | 2.88404289 |
| 96 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.86967879 |
| 97 | sperm motility (GO:0030317) | 2.86418206 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 2.86083971 |
| 99 | bile acid metabolic process (GO:0008206) | 2.86006303 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 2.84581310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.71423231 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33748698 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.05123065 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.03663208 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.01493126 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.60688351 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.60549680 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.26583699 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.23347613 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19823389 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.18337408 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04122216 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.01379886 |
| 14 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.99185729 |
| 15 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.99185729 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94566700 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93914390 |
| 18 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89268424 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88795477 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86359644 |
| 21 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.85507460 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.82582248 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81864000 |
| 24 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68456236 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67172759 |
| 26 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.65855806 |
| 27 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.62155687 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60819817 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59722854 |
| 30 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54814716 |
| 31 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.53471446 |
| 32 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.53060813 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52452200 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51256799 |
| 35 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.50942485 |
| 36 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.49985367 |
| 37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.49866325 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.49710947 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49548597 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46851317 |
| 41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44133967 |
| 42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41160764 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40544337 |
| 44 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.40108839 |
| 45 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.40108839 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38518718 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38436440 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37634306 |
| 49 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.36745726 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35864561 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34943097 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34621157 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32607450 |
| 54 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.32145393 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32061665 |
| 56 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.31266855 |
| 57 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.30406659 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29681256 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27906079 |
| 60 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27825062 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27617053 |
| 62 | AR_20517297_ChIP-Seq_VCAP_Human | 1.27482981 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26625817 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.24669323 |
| 65 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.24106612 |
| 66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.23784178 |
| 67 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.22820195 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22268057 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.22091931 |
| 70 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22027912 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21043020 |
| 72 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.20831986 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20672522 |
| 74 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.20314520 |
| 75 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.18912718 |
| 76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.17186881 |
| 77 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.17030401 |
| 78 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17002466 |
| 79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15616828 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15324324 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.14280476 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14267616 |
| 83 | JUN_21703547_ChIP-Seq_K562_Human | 1.13997617 |
| 84 | NFYA_21822215_ChIP-Seq_K562_Human | 1.12853600 |
| 85 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.12110461 |
| 86 | NFYB_21822215_ChIP-Seq_K562_Human | 1.12006586 |
| 87 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09790954 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09575947 |
| 89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09024824 |
| 90 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.07039154 |
| 91 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06364728 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06356161 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06253987 |
| 94 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06253987 |
| 95 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.06002808 |
| 96 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04047863 |
| 97 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03893599 |
| 98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03804408 |
| 99 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02632038 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01991927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.05765521 |
| 2 | MP0005360_urolithiasis | 5.91962900 |
| 3 | MP0003195_calcinosis | 4.34692982 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.88801049 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.88799490 |
| 6 | MP0005365_abnormal_bile_salt | 3.13239225 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.94167794 |
| 8 | MP0003252_abnormal_bile_duct | 2.56943203 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.50531009 |
| 10 | MP0002132_abnormal_respiratory_system | 2.30786914 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.15770336 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.14574272 |
| 13 | MP0001764_abnormal_homeostasis | 2.14126567 |
| 14 | MP0009697_abnormal_copulation | 2.04205024 |
| 15 | MP0005332_abnormal_amino_acid | 2.02813159 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.02427656 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 1.97163715 |
| 18 | MP0001188_hyperpigmentation | 1.86568740 |
| 19 | MP0005410_abnormal_fertilization | 1.84766741 |
| 20 | MP0000569_abnormal_digit_pigmentation | 1.69510783 |
| 21 | MP0001486_abnormal_startle_reflex | 1.67917783 |
| 22 | MP0003122_maternal_imprinting | 1.63787335 |
| 23 | MP0003868_abnormal_feces_composition | 1.62319790 |
| 24 | MP0005174_abnormal_tail_pigmentation | 1.55217511 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.49103927 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.44762910 |
| 27 | MP0001929_abnormal_gametogenesis | 1.40478673 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 1.38868760 |
| 29 | MP0001984_abnormal_olfaction | 1.36212529 |
| 30 | MP0009840_abnormal_foam_cell | 1.32196115 |
| 31 | MP0008995_early_reproductive_senescence | 1.30311031 |
| 32 | MP0003011_delayed_dark_adaptation | 1.27037724 |
| 33 | MP0003698_abnormal_male_reproductive | 1.24688500 |
| 34 | MP0009046_muscle_twitch | 1.23855365 |
| 35 | MP0002736_abnormal_nociception_after | 1.19968905 |
| 36 | MP0009745_abnormal_behavioral_response | 1.19446661 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.18380534 |
| 38 | MP0001963_abnormal_hearing_physiology | 1.17088818 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.16627825 |
| 40 | MP0005376_homeostasis/metabolism_phenot | 1.13904808 |
| 41 | MP0005408_hypopigmentation | 1.12391575 |
| 42 | MP0002272_abnormal_nervous_system | 1.08856336 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.08722136 |
| 44 | MP0000751_myopathy | 1.07901562 |
| 45 | MP0003646_muscle_fatigue | 1.07710077 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.07139087 |
| 47 | MP0008872_abnormal_physiological_respon | 1.06167175 |
| 48 | MP0004043_abnormal_pH_regulation | 1.01244474 |
| 49 | MP0003718_maternal_effect | 1.00480300 |
| 50 | MP0001986_abnormal_taste_sensitivity | 0.99532366 |
| 51 | MP0002928_abnormal_bile_duct | 0.99386508 |
| 52 | MP0002102_abnormal_ear_morphology | 0.99347619 |
| 53 | MP0001661_extended_life_span | 0.99191775 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 0.96241949 |
| 55 | MP0005083_abnormal_biliary_tract | 0.95703902 |
| 56 | MP0002163_abnormal_gland_morphology | 0.94398996 |
| 57 | MP0005253_abnormal_eye_physiology | 0.94240575 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 0.93800638 |
| 59 | MP0001727_abnormal_embryo_implantation | 0.92628468 |
| 60 | MP0004885_abnormal_endolymph | 0.90131050 |
| 61 | MP0000013_abnormal_adipose_tissue | 0.89329122 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 0.89300921 |
| 63 | MP0003186_abnormal_redox_activity | 0.89195747 |
| 64 | MP0002229_neurodegeneration | 0.87831403 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 0.87255978 |
| 66 | MP0005266_abnormal_metabolism | 0.87157412 |
| 67 | MP0005670_abnormal_white_adipose | 0.83125627 |
| 68 | MP0004147_increased_porphyrin_level | 0.82952982 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.82504164 |
| 70 | MP0002160_abnormal_reproductive_system | 0.77952114 |
| 71 | MP0002572_abnormal_emotion/affect_behav | 0.76731079 |
| 72 | MP0000609_abnormal_liver_physiology | 0.74897018 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 0.73995682 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.72850587 |
| 75 | MP0005499_abnormal_olfactory_system | 0.72850587 |
| 76 | MP0002161_abnormal_fertility/fecundity | 0.72372331 |
| 77 | MP0002233_abnormal_nose_morphology | 0.70572375 |
| 78 | MP0002064_seizures | 0.68063450 |
| 79 | MP0005395_other_phenotype | 0.66631371 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.65555325 |
| 81 | MP0002909_abnormal_adrenal_gland | 0.65254621 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.64580559 |
| 83 | MP0005535_abnormal_body_temperature | 0.64419687 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.64067872 |
| 85 | MP0001145_abnormal_male_reproductive | 0.63922732 |
| 86 | MP0004484_altered_response_of | 0.63282797 |
| 87 | MP0000747_muscle_weakness | 0.63273100 |
| 88 | MP0003633_abnormal_nervous_system | 0.63090770 |
| 89 | MP0004233_abnormal_muscle_weight | 0.62394953 |
| 90 | MP0002822_catalepsy | 0.61742087 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.61572630 |
| 92 | MP0001968_abnormal_touch/_nociception | 0.61555406 |
| 93 | MP0003953_abnormal_hormone_level | 0.61173144 |
| 94 | MP0002557_abnormal_social/conspecific_i | 0.61024923 |
| 95 | MP0000026_abnormal_inner_ear | 0.60885496 |
| 96 | MP0000427_abnormal_hair_cycle | 0.60556236 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.60327651 |
| 98 | MP0000653_abnormal_sex_gland | 0.60132746 |
| 99 | MP0005389_reproductive_system_phenotype | 0.60057144 |
| 100 | MP0004883_abnormal_blood_vessel | 0.59692472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type II lissencephaly (HP:0007260) | 4.69018836 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.59899213 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.43425495 |
| 4 | Renal cortical cysts (HP:0000803) | 4.24404498 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.05343734 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 3.99756111 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.95840400 |
| 8 | Xanthomatosis (HP:0000991) | 3.87301315 |
| 9 | Retinal dysplasia (HP:0007973) | 3.45183209 |
| 10 | Epidermoid cyst (HP:0200040) | 3.33646217 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.32175533 |
| 12 | Bile duct proliferation (HP:0001408) | 3.22456413 |
| 13 | Abnormal biliary tract physiology (HP:0012439) | 3.22456413 |
| 14 | Hyperglycinemia (HP:0002154) | 3.20242092 |
| 15 | Complement deficiency (HP:0004431) | 3.13515657 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.06093393 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.00545665 |
| 18 | Abnormality of the renal cortex (HP:0011035) | 3.00203158 |
| 19 | Glycosuria (HP:0003076) | 2.92083374 |
| 20 | Abnormality of urine glucose concentration (HP:0011016) | 2.92083374 |
| 21 | Generalized aminoaciduria (HP:0002909) | 2.86539566 |
| 22 | Abnormality of DNA repair (HP:0003254) | 2.78036357 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.77088337 |
| 24 | Pancreatic cysts (HP:0001737) | 2.75175838 |
| 25 | Optic nerve hypoplasia (HP:0000609) | 2.73674028 |
| 26 | Hypolipoproteinemia (HP:0010981) | 2.73212786 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.73002523 |
| 28 | Absent speech (HP:0001344) | 2.70995639 |
| 29 | Chronic hepatic failure (HP:0100626) | 2.66124225 |
| 30 | Polyphagia (HP:0002591) | 2.65489893 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 2.64911958 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.55918451 |
| 33 | Acute encephalopathy (HP:0006846) | 2.53594094 |
| 34 | Joint hemorrhage (HP:0005261) | 2.47994064 |
| 35 | Reticulocytosis (HP:0001923) | 2.45275091 |
| 36 | Acanthocytosis (HP:0001927) | 2.42083599 |
| 37 | Cerebellar dysplasia (HP:0007033) | 2.38153582 |
| 38 | Glomerulonephritis (HP:0000099) | 2.36825372 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.36178667 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.36178667 |
| 41 | Hyperglycinuria (HP:0003108) | 2.30394753 |
| 42 | Hypoproteinemia (HP:0003075) | 2.27008022 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 2.22788873 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.22703021 |
| 45 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.22033366 |
| 46 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.21528899 |
| 47 | Brushfield spots (HP:0001088) | 2.19692333 |
| 48 | Poikilocytosis (HP:0004447) | 2.16398438 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.12205169 |
| 50 | Amblyopia (HP:0000646) | 2.10482878 |
| 51 | Supernumerary spleens (HP:0009799) | 2.10425721 |
| 52 | Retinal atrophy (HP:0001105) | 2.09305236 |
| 53 | Cerebral edema (HP:0002181) | 2.04694753 |
| 54 | Abnormality of complement system (HP:0005339) | 2.03281440 |
| 55 | Degeneration of anterior horn cells (HP:0002398) | 2.01237545 |
| 56 | Abnormality of the anterior horn cell (HP:0006802) | 2.01237545 |
| 57 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.97661790 |
| 58 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.97661790 |
| 59 | Hyperammonemia (HP:0001987) | 1.95606504 |
| 60 | Lethargy (HP:0001254) | 1.93328352 |
| 61 | Progressive inability to walk (HP:0002505) | 1.93261767 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 1.91593980 |
| 63 | Lissencephaly (HP:0001339) | 1.90769791 |
| 64 | Limb dystonia (HP:0002451) | 1.90631145 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90506825 |
| 66 | Hyperbilirubinemia (HP:0002904) | 1.90380380 |
| 67 | Pancreatic fibrosis (HP:0100732) | 1.89132400 |
| 68 | Delayed CNS myelination (HP:0002188) | 1.88214700 |
| 69 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87793865 |
| 70 | Abnormal albumin level (HP:0012116) | 1.87773887 |
| 71 | Hypoalbuminemia (HP:0003073) | 1.87773887 |
| 72 | Hyperventilation (HP:0002883) | 1.86273718 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 1.84643360 |
| 74 | Abnormal glycosylation (HP:0012345) | 1.84643360 |
| 75 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84643360 |
| 76 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84643360 |
| 77 | Abnormality of the vitreous humor (HP:0004327) | 1.82992870 |
| 78 | True hermaphroditism (HP:0010459) | 1.82854057 |
| 79 | Abnormality of the ileum (HP:0001549) | 1.82112755 |
| 80 | Gaze-evoked nystagmus (HP:0000640) | 1.81381184 |
| 81 | Mesangial abnormality (HP:0001966) | 1.81262311 |
| 82 | Inability to walk (HP:0002540) | 1.79715594 |
| 83 | Abolished electroretinogram (ERG) (HP:0000550) | 1.79521300 |
| 84 | Hepatic necrosis (HP:0002605) | 1.77767907 |
| 85 | Metabolic acidosis (HP:0001942) | 1.77050951 |
| 86 | Febrile seizures (HP:0002373) | 1.71980343 |
| 87 | Meckel diverticulum (HP:0002245) | 1.70603021 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70546823 |
| 89 | Spastic tetraplegia (HP:0002510) | 1.69344799 |
| 90 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.69330269 |
| 91 | Gingival bleeding (HP:0000225) | 1.68843634 |
| 92 | Abnormality of macular pigmentation (HP:0008002) | 1.68655756 |
| 93 | Albinism (HP:0001022) | 1.68298227 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 1.68078181 |
| 95 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.67460819 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 1.67460819 |
| 97 | Poikiloderma (HP:0001029) | 1.66631350 |
| 98 | Abnormality of dental color (HP:0011073) | 1.64509711 |
| 99 | Hyperphosphaturia (HP:0003109) | 1.64294285 |
| 100 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.63720763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 6.53983268 |
| 2 | WNK3 | 4.44713885 |
| 3 | TRIM28 | 4.16418178 |
| 4 | PLK4 | 4.11831080 |
| 5 | MAP3K4 | 3.84878553 |
| 6 | MAP4K2 | 3.65850381 |
| 7 | ZAK | 2.76060502 |
| 8 | ADRBK2 | 2.62590326 |
| 9 | MAP2K7 | 2.32493928 |
| 10 | EPHA3 | 2.06646451 |
| 11 | MAPK13 | 2.02353465 |
| 12 | NUAK1 | 1.75879459 |
| 13 | STK38L | 1.73537417 |
| 14 | RPS6KA4 | 1.72015676 |
| 15 | UHMK1 | 1.60285208 |
| 16 | BCR | 1.52926534 |
| 17 | TAOK3 | 1.38405462 |
| 18 | PLK2 | 1.32381493 |
| 19 | CDK19 | 1.32304487 |
| 20 | BRSK2 | 1.30196971 |
| 21 | INSRR | 1.27171540 |
| 22 | FRK | 1.23407988 |
| 23 | OXSR1 | 1.21710098 |
| 24 | BCKDK | 1.16831478 |
| 25 | MAP2K4 | 1.16795831 |
| 26 | PINK1 | 1.05074456 |
| 27 | SIK3 | 1.02529086 |
| 28 | NME1 | 1.00396057 |
| 29 | MARK1 | 0.99263879 |
| 30 | NEK6 | 0.98717496 |
| 31 | BMPR2 | 0.98227595 |
| 32 | TLK1 | 0.97674645 |
| 33 | MAPK11 | 0.96266444 |
| 34 | PDK2 | 0.91657365 |
| 35 | NTRK2 | 0.90296541 |
| 36 | ACVR1B | 0.89996634 |
| 37 | DYRK1A | 0.88766151 |
| 38 | BRD4 | 0.88543149 |
| 39 | STK38 | 0.80715157 |
| 40 | MAP3K5 | 0.79780007 |
| 41 | GRK1 | 0.77457376 |
| 42 | RPS6KA5 | 0.75444866 |
| 43 | CDK18 | 0.70742509 |
| 44 | SRPK1 | 0.69138817 |
| 45 | CAMK2G | 0.66093223 |
| 46 | DAPK2 | 0.64073643 |
| 47 | CDC7 | 0.63388841 |
| 48 | WNK4 | 0.62829231 |
| 49 | PRKCG | 0.61289749 |
| 50 | PIK3CG | 0.60945651 |
| 51 | MAP3K12 | 0.60923452 |
| 52 | CDK15 | 0.60899236 |
| 53 | GRK7 | 0.59846179 |
| 54 | PRKCE | 0.59017797 |
| 55 | CSNK1G3 | 0.58452753 |
| 56 | CSNK1G1 | 0.58175989 |
| 57 | CDK11A | 0.55988836 |
| 58 | CDK14 | 0.52551605 |
| 59 | CAMK2B | 0.52284628 |
| 60 | TXK | 0.51259671 |
| 61 | TYK2 | 0.50319701 |
| 62 | PRKD3 | 0.49905887 |
| 63 | PRKCQ | 0.49836624 |
| 64 | PRKAA1 | 0.49038852 |
| 65 | FER | 0.48667582 |
| 66 | CSNK1G2 | 0.48373119 |
| 67 | PNCK | 0.47094187 |
| 68 | DYRK2 | 0.46556871 |
| 69 | CAMK4 | 0.44795412 |
| 70 | CDK3 | 0.44273583 |
| 71 | CAMK2D | 0.44074745 |
| 72 | BMPR1B | 0.43825778 |
| 73 | PRKACG | 0.42840617 |
| 74 | CAMK2A | 0.40964943 |
| 75 | PRKAA2 | 0.40227495 |
| 76 | PAK3 | 0.40024846 |
| 77 | NTRK3 | 0.39291749 |
| 78 | ERBB4 | 0.38501312 |
| 79 | KSR1 | 0.37898606 |
| 80 | PRKCZ | 0.37516944 |
| 81 | BRSK1 | 0.36541208 |
| 82 | LMTK2 | 0.36461957 |
| 83 | WEE1 | 0.35999082 |
| 84 | PRKACA | 0.35877006 |
| 85 | LIMK1 | 0.35361000 |
| 86 | RAF1 | 0.34682406 |
| 87 | DYRK1B | 0.33007911 |
| 88 | ITK | 0.32062410 |
| 89 | PLK1 | 0.31943008 |
| 90 | CSNK1A1 | 0.31281535 |
| 91 | CDK5 | 0.31027138 |
| 92 | SIK2 | 0.30771815 |
| 93 | TESK1 | 0.30513222 |
| 94 | VRK1 | 0.30373263 |
| 95 | JAK1 | 0.30013380 |
| 96 | SGK223 | 0.28204870 |
| 97 | SGK494 | 0.28204870 |
| 98 | NLK | 0.27691253 |
| 99 | ERBB2 | 0.26077253 |
| 100 | MAP3K7 | 0.25503190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.66638038 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.03481055 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63715896 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62323837 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 2.57459765 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47668344 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43665441 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39977590 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.30396513 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23639795 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17863313 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.15497262 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.15396414 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.09664635 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06423387 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99957576 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.98452862 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.97276928 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.95677483 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94543538 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.94328780 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.89633645 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81278450 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.81256138 |
| 25 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.75052536 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.68829401 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.68224757 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64730661 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63206978 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61037512 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.59390499 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54820136 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52432902 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.30465563 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.28975346 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.28810433 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28257608 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27233591 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22702866 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20353946 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14413190 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14088247 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13383980 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.10999706 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09651020 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06903864 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04947666 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.03875233 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97898452 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97082469 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96749018 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95842381 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92557826 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92438726 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82495410 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78858106 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77441979 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76759287 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 0.71940500 |
| 60 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71489629 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71100748 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69807430 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69415168 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66299012 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65384146 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65179329 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62867822 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.61232790 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60376552 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59383789 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59305542 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58935932 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57681772 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.57009694 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55975839 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55416114 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53477224 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52939293 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50876358 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.47827437 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47300867 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46784283 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38271814 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.37412915 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36285788 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34540030 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33735357 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32969495 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27702213 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.26804375 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.25717093 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24949236 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.22532234 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.18909468 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.17602113 |
| 96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.17494274 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17467631 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.17002545 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.16558409 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.15716652 |

